Skip to content

Author

V. Matveev

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Evolution of darolutamide evidence base: review of new data from international congresses and their role in personalization of systemic therapy selection

The ARASAFE, ARASEC, and ARACOG studies, the results of which were presented at major international congresses in 2026, are designed to address gaps in the transition toward a personalized model of systemic therapy selection for patients with advanced prostate cancer.

V. Matveev, A. Klimov, N. D. Novichkov · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.